Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
TD Cowen: 'We Expect Vera Therapeutics (VERA) Shares To Be Up Likely 50-75%'
-
Vera Therapeutics to Participate in the TD Cowen 45th Annual Health Care Conference
-
TD Cowen Reiterates Buy Rating on Vera Therapeutics (VERA)
-
Vera Therapeutics to Participate at the 44th Annual TD Cowen Health Care Conference
-
Vera Therapeutics (VERA) Prices Upsized 8.06M Share Offering at $31/sh
-
Vera Therapeutics Announces Pricing of Upsized Public Offering of Class A Common Stock
-
Vera Therapeutics (VERA) Terminates ATM Offering
-
Vera Therapeutics to Participate in the Cowen 43rd Annual Health Care Conference
-
Vera Therapeutics to Participate in the Cowen 43rd Annual Health Care Conference
-
Vera Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of Class A Common Stock
-
Vera Therapeutics Inc. (VERA) Prices 14.29M Share Offering at $7/sh
-
Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock
-
Vera Therapeutics Inc. (VERA) Commences $75M Share Offering
-
Vera Therapeutics Announces Commencement of Public Offering of Class A Common Stock
-
Vera Therapeutics (VERA) stock crashes 60% on trial data, Evercore 'comfortably buying weakness'
-
This pharma stock could gain up to 40% on upcoming trial results - Cowen
-
Cowen Reiterates Outperform Rating on Vera Therapeutics (VERA)
-
Vera Therapeutics Inc. (VERA) Reports Q4 Results
-
Vera Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
-
Vera Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
-
Vera Therapeutics to Participate in the 42nd Annual Cowen Health Care Conference
-
Vera Therapeutics to Participate in the 42nd Annual Cowen Health Care Conference
-
Vera Therapeutics Announces Closing of Upsized Public Offering of Class A Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Vera Therapeutics Inc. (VERA) Prices Upsized 4.99M Share Offering at $15/sh
-
Vera Therapeutics Announces Pricing of Upsized Public Offering of Class A Common Stock
-
Vera Therapeutics Announces Pricing of Upsized Public Offering of Class A Common Stock
-
Vera Therapeutics Inc. (VERA) Announces Commencement of 4M Share Public Offering of Class A Common Stock
-
Vera Therapeutics Announces Commencement of Public Offering of Class A Common Stock
-
UPDATE: Cowen Starts Vera Therapeutics (VERA) at Outperform
-
Vera Therapeutics Inc. (VERA) IPO Opens, Trades Higher
-
Vera Therapeutics Inc. (VERA) Prices 4.35M Share IPO at $11/Sh
-
Vera Therapeutics Announces Pricing of Initial Public Offering

